Membrane Receptor and Antiangiogenic Targeted Therapies in the Treatment of Cancer

E-ISSN： 1875-6301|1|1|51-61

ISSN： 1573-3947

Source： Current Cancer Therapy Reviews, Vol.1, Iss.1, 2005-01, pp. : 51-61

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The evolving role of VEGF-targeted therapies in the treatment of metastatic colorectal cancer

By Fakih Marwan

Expert Review of Anticancer Therapy, Vol. 13, Iss. 4, 2013-04 ,pp. : 427-438

Informa Healthcare

Access to resources Recommend Favorite

Targeted Therapies for Metastatic Esophagogastric Cancer

By Reddy Deepa

Current Treatment Options in Oncology, Vol. 12, Iss. 1, 2011-03 ,pp. : 46-60

Springer Publishing Company

Access to resources Recommend Favorite

Antiangiogenic treatment approaches in breast cancer

By Bartsch Rupert Berghoff Anna S Preusser Matthias Steger Guenther G Zielinski Christoph C

Breast Cancer Management, Vol. 2, Iss. 5, 2013-09 ,pp. : 397-406

Future Medicine

Access to resources Recommend Favorite

Recent Developments in Targeted Therapies of the RAF-MEK and PI3KAKT Pathways in Cancer Treatment

Current Cancer Therapy Reviews, Vol. 8, Iss. 3, 2012-01 ,pp. : 205-217

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted therapies in small cell lung cancer (Review)

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 3-11

Spandidos Publications

Access to resources Recommend Favorite